Curocell to retry CAR-T Rimqarto reimbursement in July after first HIRA setback Korea Biomedical Review 02:29 Thu, 28 May
Curocell bets on faster access as Korea’s 1st homegrown CAR-T enters market Korea Biomedical Review 07:00 Thu, 14 May
